Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Neuzumab 150mg Injection

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Trastuzumab (150mg)

Overview Neuzumab 150mg Injection

Oncaspar, a 150mg injectable formulation, is indicated in the management of breast and gastric cancers. Its mechanism involves targeted destruction of cancerous cells via HER2 receptor blockade (human epidermal growth factor receptor 2). Administration is strictly by injection under the supervision of a qualified healthcare provider. Dosage frequency and regimen are determined individually by your physician, contingent upon your specific condition and subject to modification. Adhere precisely to your prescribed schedule; incorrect usage or overdose may lead to severe adverse events. Therapeutic effects might not be immediately apparent; continued use, as directed, is crucial unless otherwise advised by your doctor. Frequently reported side effects encompass nausea, cephalgia, dermatological reactions, sleep disturbances, and infections. A reduction in blood cell counts (including erythrocytes and leukocytes), elevating infection risk, is possible. Regular hematological monitoring, along with assessments of cardiac function, hepatic health, and uric acid levels, are mandatory. Report immediately any symptoms such as dyspnea, cough, chills, or limb edema. Significant drug interactions are possible; inform your healthcare team of all concurrent medications. Use during pregnancy or lactation is contraindicated; effective contraception for both partners is essential throughout treatment.

Uses of Neuzumab 150mg Injection

Cancers affecting the breast and stomach.

Major Benefits of Neuzumab 150mg Injection:

Administering this medication requires a healthcare professional; self-medication is strictly prohibited.

Common Side effects of Neuzumab 150mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Neuzumab 150mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

How Neuzumab 150mg Injection works:

The injectable medication Neuzumab 150mg is a genetically engineered monoclonal antibody (IgG1 isotype). Its mechanism of action targets HER2 (human epidermal growth factor receptor 2), a protein that overstimulates breast and stomach cancer cell growth. By binding to HER2, Neuzumab disrupts the receptor's function and eliminates cancer cells. This action also suppresses multiple downstream signaling cascades implicated in cancer development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Neuzumab 150mg Injection and alcohol can result in pronounced somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Neuzumab 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Neuzumab 150mg Injection while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Neuzumab 150mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of Neuzumab 150mg Injection in patients with impaired renal function appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary for this population. Physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of 150mg Neuzumab injections to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Neuzumab 150mg Injection :

Should you forget a scheduled dose of the Neuzumab 150mg Injection, seek advice from your physician.

Facts to Know About Neuzumab 150mg Injection

LabelValue
Chemical Category Monoclonal antibody
Developing Habits No.
Type of Therapy Cancer Treatments
Action Category Monoclonal antibody HER2/neu (ErbB2) inhibitor

FAQs on Neuzumab 150mg Injection

Neuzumab 150mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bleeding or bruising. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea, vomiting, loss of appetite, rapid heartbeat, urine discoloration, decreased urination, painful urination, and signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Effective contraception is recommended for women of childbearing age throughout Neuzumab 150mg Injection therapy and for seven months afterward. Pregnancy planning may resume seven months post-treatment.
Treatment with Neuzumab 150mg Injection for early breast cancer should continue for one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Neuzumab 150mg Injection does not require fasting beforehand. Administration must be supervised by a doctor experienced in cancer chemotherapy and performed only by a qualified healthcare professional.
Neuzumab 150mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous (SC) injection. Always verify the correct formulation is administered as prescribed, as the IV formulation is exclusively for intravenous use. Your doctor may change your treatment between the IV and SC formulations if clinically appropriate.
Neuzumab 150mg Injection is a monoclonal antibody targeting the HER2 protein, found on the surface of some cancer cells. Because it works by binding to HER2 to inhibit cancer growth, it's only effective in patients with HER2-positive cancer; it's not indicated for use in HER2-negative patients.
Using Neuzumab 150mg Injection with anthracyclines (like doxorubicin) can harm your heart. Your doctor must assess your heart health before and during treatment.
Cardiac evaluations should begin at treatment initiation, continue every three months during treatment, and then every six months post-treatment for up to 24 months following the final Neuzumab 150mg Injection dose. Patients with pre-existing cardiac conditions require evaluations every 12 weeks.
Neuzumab 150mg Injection
7,305
MRP 8,900
17% off